Thermogenesis announces 1-for-45 reverse stock split

Rancho cordova, calif. , dec. 21, 2022 /prnewswire/ -- thermogenesis holdings, inc. (nasdaq: thmo) (the "company"), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced a 1-for-45 reverse stock split of its outstanding common stock, effective at 12:01 a.m.

THMO Ratings Summary

THMO Quant Ranking